The Union Government has entered into an agreement with World Bank for flexible financing arrangement to accelerate research towards early development for biopharmaceuticals under National Biopharma Mission.
The agreement was signed between
Project implementing agency, Biotechnology Industry Research Assistance Council (BIRAC), a PSU of Department of Biotechnology,
Department of Economic Affairs, Ministry of Finance and
International Bank for Reconstruction and Development (IBRD) on behalf of World Bank.
National Biopharmaceutical Mission is the first ever Industry-Academia mission to accelerate biopharmaceutical development in India. This programme has been named Innovate in India (i3).
The mission was launched by Ministry of Science & Technology in 2017 at a total cost of US $250 million for five years with 50% funding through World Bank Loan.
The objective of this programme is to make India a hub for design and development of novel, affordable and effective biopharmaceutical products.